Tesla’s European joyride is skidding hard in April, with sales nose-diving across key markets like Sweden, Denmark, and ...

Nebula Research & Development LLC more than doubled its Chevron holdings in Q4, snapping up 5,165 additional shares worth ...

Eli Lilly’s Q1 earnings smashed expectations, fueled by surging demand for its blockbuster drugs Zepbound and Mounjaro. The ...

UnitedHealth Group saw its price target slashed from $640 to $510 by Robert W. Baird, despite maintaining an “outperform” ...

The Manufacturers Life Insurance Company reduced its Home Depot holdings by 4.7% in Q4, selling 38,498 shares. This left the ...

Perbak Capital Partners just dove into Danaher with a tidy $1.1 million buy of 4,911 shares, joining a growing bandwagon of ...

Apple shares dipped nearly 3% after CEO Tim Cook revealed a looming $900 million tariff toll this quarter and scaled down ...

Southern Copper just got a lukewarm upgrade from HSBC Global Res, shifting from “moderate sell” to “hold”—which is basically ...

Analysts at Cantor Fitzgerald shaved a whopping two cents off their FY2025 EPS forecast for AbbVie, from $12.33 to $12.31, ...

Investors are eagerly awaiting Berkshire Hathaway’s Q1 results to find out if Warren Buffett dipped into his record $334 ...

Mission Creek Capital Partners Inc. jumped into the financial fray by acquiring 21,444 shares of Bank of America, a stake ...

Salesforce continues charming Wall Street, as Westpark Capital reaffirmed its "buy" rating and pegged a $320 target, hinting ...